Detalhe da pesquisa
1.
Blood Eosinophils: A Biomarker of Response to Extrafine Beclomethasone/Formoterol in Chronic Obstructive Pulmonary Disease.
Am J Respir Crit Care Med;
192(4): 523-5, 2015 Aug 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26051430
2.
Fibrocyte localisation to the ASM bundle in asthma: bidirectional effects on cell phenotype and behaviour.
Clin Transl Immunology;
9(11): e1205, 2020.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33209301
3.
DP2 antagonism reduces airway smooth muscle mass in asthma by decreasing eosinophilia and myofibroblast recruitment.
Sci Transl Med;
11(479)2019 02 13.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30760581
4.
Blood eosinophils: a biomarker of COPD exacerbation reduction with inhaled corticosteroids.
Int J Chron Obstruct Pulmon Dis;
13: 3669-3676, 2018.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30464449
5.
Fevipiprant, a prostaglandin D2 receptor 2 antagonist, in patients with persistent eosinophilic asthma: a single-centre, randomised, double-blind, parallel-group, placebo-controlled trial.
Lancet Respir Med;
4(9): 699-707, 2016 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27503237